Cargando…

An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report

BACKGROUND: Donor acute lymphoblastic leukemia with recipient intact is a rare condition. We report a case of donor developing acute lymphoblastic leukemia 8 yrs after donating both bone marrow and peripheral blood hematopoietic stem cells. CASE PRESENTATION: This case report describes a 51-year old...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Di, Xie, Ting, Chen, Suning, Ling, Yipeng, Xu, Yueyi, Chen, Bing, Ouyang, Jian, Yang, Yonggong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060641/
https://www.ncbi.nlm.nih.gov/pubmed/32143579
http://dx.doi.org/10.1186/s12885-020-6681-2
_version_ 1783504276353449984
author Zhou, Di
Xie, Ting
Chen, Suning
Ling, Yipeng
Xu, Yueyi
Chen, Bing
Ouyang, Jian
Yang, Yonggong
author_facet Zhou, Di
Xie, Ting
Chen, Suning
Ling, Yipeng
Xu, Yueyi
Chen, Bing
Ouyang, Jian
Yang, Yonggong
author_sort Zhou, Di
collection PubMed
description BACKGROUND: Donor acute lymphoblastic leukemia with recipient intact is a rare condition. We report a case of donor developing acute lymphoblastic leukemia 8 yrs after donating both bone marrow and peripheral blood hematopoietic stem cells. CASE PRESENTATION: This case report describes a 51-year old female diagnosed with acute lymphoblastic leukemia who donated both bone marrow and peripheral blood stem cells 8 yrs ago for her brother with severe aplastic anemia. Whole exome sequencing revealed leukemic genetic lesions (SF3B1 and BRAF mutation) only appeared in the donor sister, not the recipient, and an unusual type of hematopoietic stem cell transplantation with the recipient’s peripheral blood stem cells was done. The patient remained in remission for 3 months before disease relapsed. CD19 CAR-T therapy followed by HLA-identical unrelated hematopoietic stem cell transplantation was applied and the patient remains in remission for 7 months till now. CONCLUSIONS: This donor leukemia report supports the hypothesis that genetic lesions happen randomly in leukemogenesis. SF3B1 combined with BRAF mutation might contribute to the development of acute lymphoblastic leukemia.
format Online
Article
Text
id pubmed-7060641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70606412020-03-11 An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report Zhou, Di Xie, Ting Chen, Suning Ling, Yipeng Xu, Yueyi Chen, Bing Ouyang, Jian Yang, Yonggong BMC Cancer Case Report BACKGROUND: Donor acute lymphoblastic leukemia with recipient intact is a rare condition. We report a case of donor developing acute lymphoblastic leukemia 8 yrs after donating both bone marrow and peripheral blood hematopoietic stem cells. CASE PRESENTATION: This case report describes a 51-year old female diagnosed with acute lymphoblastic leukemia who donated both bone marrow and peripheral blood stem cells 8 yrs ago for her brother with severe aplastic anemia. Whole exome sequencing revealed leukemic genetic lesions (SF3B1 and BRAF mutation) only appeared in the donor sister, not the recipient, and an unusual type of hematopoietic stem cell transplantation with the recipient’s peripheral blood stem cells was done. The patient remained in remission for 3 months before disease relapsed. CD19 CAR-T therapy followed by HLA-identical unrelated hematopoietic stem cell transplantation was applied and the patient remains in remission for 7 months till now. CONCLUSIONS: This donor leukemia report supports the hypothesis that genetic lesions happen randomly in leukemogenesis. SF3B1 combined with BRAF mutation might contribute to the development of acute lymphoblastic leukemia. BioMed Central 2020-03-06 /pmc/articles/PMC7060641/ /pubmed/32143579 http://dx.doi.org/10.1186/s12885-020-6681-2 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Zhou, Di
Xie, Ting
Chen, Suning
Ling, Yipeng
Xu, Yueyi
Chen, Bing
Ouyang, Jian
Yang, Yonggong
An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
title An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
title_full An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
title_fullStr An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
title_full_unstemmed An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
title_short An unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
title_sort unusual hematopoietic stem cell transplantation for donor acute lymphoblastic leukemia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060641/
https://www.ncbi.nlm.nih.gov/pubmed/32143579
http://dx.doi.org/10.1186/s12885-020-6681-2
work_keys_str_mv AT zhoudi anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT xieting anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT chensuning anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT lingyipeng anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT xuyueyi anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT chenbing anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT ouyangjian anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT yangyonggong anunusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT zhoudi unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT xieting unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT chensuning unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT lingyipeng unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT xuyueyi unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT chenbing unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT ouyangjian unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport
AT yangyonggong unusualhematopoieticstemcelltransplantationfordonoracutelymphoblasticleukemiaacasereport